Aanem Presents Nerve And Muscle Junction

Dr. Willer interviews Dr. Caress on his article, COVID-19-Associated Guillain-Barre Syndrome: The Early Pandemic Experience. Please review these papers that were mentioned in this podcast: "Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barre syndrome" "COVID-19 vaccine and Guillain-Barre ́syndrome: let's not leap to associations"

Dr. Willer interviews Dr. Caress on his article, COVID-19-associated Guillain-Barre syndrome: The early pandemic experience. Please review these papers that were mentioned in this podcast: "Epidemiological and Cohort Study Finds No Association Between COVID-19 and Guillain-Barre syndrome." "COVID-19 Vaccine and Guillain-Barre syndrome: Let's Not Leap to Associations."

Dr. Patel interviews Dr. Stino on his article, Autonomic Neuropathies.

Dr. Patel interviews Dr. Stino on his article, Autonomic Neuropathies.

Dr. Waheed interviews Dr. LoRusso and Dr. Statland on thier article, Guidelines on clinical presentation and management of nondystrophic myotonias.

Dr. Waheed interviews Drs. LoRusso and Statland on their article, Guidelines on clinical presentation and management of nondystrophic myotonias.

Dr. Elie Naddaf interviews Drs. Amanda Guidon and Anthony Amato regarding COVID-19 and neuromuscular disorders. This podcast reviews the potential neuromuscular complications of COVID-19, impact of COVID-19 on patients with preexisting neuromuscular disease, and guidance for management of immunosuppressive and immunomodulatory therapies and timing vaccination. We also review the impact of COVID-19 on training in neuromuscular and electrodiagnostic medicine.

Dr. Elie Naddaf interviews Dr. Andrea Boon about the approach to patients presenting to the EMG laboratory with respiratory symptoms, to evaluate for underlying neuromuscular cause of these symptoms. Dr Boon describes the role of phrenic nerve conduction studies and needle electromyography of the diaphragm and the technical limitations of these studies. Dr Boon also details the role of diaphragm ultrasound to enhance the accuracy and safety of diaphragm electromyography, and improve the diagnostic yield of EDX testing, including an overview of the diaphragm ultrasound technique

Dr. Sandra Hearn interviews Dr. Dr. Darryl Sneag, Dr. Danielle Stoner, Dr. Scott Wolfe, Dr. Joseph Feinberg, Anterior interosseous nerve syndrome.

Dr. Ibanez interviewing Dr. Elliott on “Rehabilitative approach to ALS patients” while also highlighting his article “Eye-controlled, power wheelchair performs well for ALS patients.

Dr. Justin Willer interviews Dr. Constantine Farmakidis on his article, Immunomodulatory and Immunosuppressive Therapy for Neuromuscular Disorders Part II.

Dr. Justin Willer interviews Dr. Constantine Farmakidis on his article, Immunomodulatory and Immunosuppressive Therapy for Neuromuscular Disorders Part I.

Dr. Priya Dhawan interviews Dr. Kelly Gwathmey on her article, Nutritional Neuropathies.

Dr. Elie Naddaf interviews Dr. Andrea Leep Hunderfund on her article, Quality Improvement Projects in the EMG laboratory.

Dr. Elahi Behzad interviews Dr. Srikanth Muppidi on his article, Long-term Safety and Efficacy of Eculizumab in Generalized Myasthenia Gravis.

Dr. Sandra Hearn interviews Dr. John Norbury on his article, Ultrasound-Guided Treatment of Peripheral Entrapment Neuropathies.

Dr. Elie Naddaf interviews Lawrence R. Robinson MD on his article, Effect of shoulder and elbow position on ulnar nerve conduction.

Dr. Justin Willer interviews Dr. Michael Hehir on his article, Thymectomy may not be associated with clinical improvement in MuSK myasthenia gravis.

Dr. Elie Naddaf interviews Dr. Mazen Dimachkie on his article, Satisfactory Response With Achieving Maintenance Low-Dose Prednisone in Generalized Myasthenia Gravis. To estimate the satisfactory response rate (SR%) with achieving maintenance, low-dose prednisone in acetylcholine receptor antibody-positive generalized myasthenia gravis. In this retrospective study, we estimate the SR% as defined by (remission/minimal manifestations status for at least 6 months using 7.5 mg or less of prednisone daily, for maintenance treatment at 2, 4, and 6 years after symptoms onset) for patients who were not taking steroid-sparing immunosuppressant (SSI) as a primary outcome and for patients taking an SSI as a secondary outcome. Forty-five patients were not taking an SSI at 2 years, 34 patients at 4 years, and 17 patients at 6 years; SR% was 44.4%, 64.7%, and 58.8%, respectively. Thirty-six patients were taking an SSI at 2 years, 22 patients at 4 years, and 15 patients at 6 years; the SR% was 50.0%, 45.4%, and 66.7%, respec

Dr. Justin Willer interviews Dr. Yuebing Li about his article, Clinical and Electrodiagnostic Features Of Nontraumatic Sciatic Neuropathy. This study sought to characterize etiologies and features of sciatic neuropathy unrelated to penetrating nerve trauma. Methods: This investigation was a retrospective review of 109 patients with electrodiagnostically confirmed sciatic neuropathies. Results: Hip replacement surgery represented the most common (34.9%) etiology, whereas inflammatory sciatic neuropathy was seen in 7.3%. Electrodiagnostic testing revealed an axonal neuropathy in 95.4% and a demyelinating neuropathy in 4.6%. Predominant involvement of the peroneal division was seen in 39.4% and was tibial in 5.5%. Nine of 31 (29.0%) patients who had MRI or neuromuscular ultrasound study showed abnormalities within the sciatic nerve. At the final visit, 46.4% of patients required assistance for ambulation. Young age, lack of severe initial weakness, and presence of tibial compound muscle action potential or sural